Upgrade to SI Premium - Free Trial

Marvell (MRVL) PT Lowered to $13 at BofA/Merrill Lynch on Weak Qtr

February 20, 2015 7:42 AM
BofA/Merrill Lynch analyst Vivek Arya reiterated an Underperform rating and lowered its price target on Marvell (NASDAQ: MRVL) to $13.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles